ClinicalTrials.Veeva

Menu

Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy

K

Kulsoom International Hospital

Status and phase

Enrolling
Phase 4

Conditions

Opioid
Enhanced Recovery After Surgery (ERAS) Protocol
Erector Spinae Block

Treatments

Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT07178262
ERC-030

Details and patient eligibility

About

Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.

Full description

Total abdominal hystrectomy is associated with significant pain due to large abdominal incision and significant surgical dissection. This greatly increases the consumption of Opioid in the peri-operative period. High dose opioid consumption is associated with constipation, nausea, vomiting and respiratory depression. This significantly hampers post operative recovery. Fascial plane blocks such as Erector spinae block provides significant analgesia greatly reducing opioid consumption and there by reducing the associated side effects.

Enrollment

60 estimated patients

Sex

Female

Ages

16 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) class: I, II and III .
  • Elective Hysterectomy under General Anesthesia.

Exclusion criteria

  • Lack of consent
  • Body mass index >35 kg/m2
  • Allergic to study medicine
  • Opioid abuse or misuse disorder
  • Chronic pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Erector spinae group
Active Comparator group
Description:
Patients in this group will receive bilateral erector spinae block at T10 level using 30ml of 0.25% Bupivacaine before surgical incision.
Treatment:
Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Placebo
Placebo Comparator group
Description:
Patient in this group will receive Norma saline in Erector spinae block at T10 level bilaterally before surgical incision.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Abdul Rehman, MBBS,FCPS; Waqas Anjum, Principal Investigator, MBBS, FCPS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems